Áreas terapeúticas

Think Fabry, think screening at-risk family members.¹

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.^1,2

El video demuestra el proceso completo para la correcta preparación y administración de Sarclisa (isatuximab) por profesionales de la salud. Herramienta educativa para garantizar la administración segura y efectiva de Sarclisa en pacientes con mieloma múltiple.

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.¹

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.¹